SOUTH SAN FRANCISCO, CA--(Marketwire - March 01, 2010) - Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced that the Company is scheduled to participate in the following events in March:
RBC Capital Markets 2010 Healthcare Conference
Panel: “Cancer: Improving Treatment through Combination Therapy”
Wednesday, March 3, 2010 at 8:00 a.m. Eastern Time at the New York Palace Hotel in New York City;- Cowen and Company 30th Annual Healthcare Conference
Wednesday, March 10, 2010 at 8:45 a.m. Eastern Time at the Boston Marriott Copley Place Hotel in Boston.
Live webcasts of the events will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcasts will be archived on the “Calendar of Events” page in the Investors and Media section of the Sunesis website for two weeks following the respective dates of the presentations.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
Andrea Rabney
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
